Supraclavicular Block vs Retroclavicular Block: Incidence of Phrenic Nerve Paralysis

Sponsor
Brigham and Women's Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT02631122
Collaborator
(none)
44
1
2
18.4
2.4

Study Details

Study Description

Brief Summary

The aim of this study is to evaluate differences between ultrasound guided supraclavicular versus retroclavicular brachial plexus blocks: two similar brachial plexus nerve block techniques that differ in their needle trajectory and injection site.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Supraclavicular vs Retroclavicular Nerve Block
N/A

Detailed Description

To date, there has not been a study that has compared clinically the retroclavicular brachial plexus block to the supraclavicular brachial plexus block or other brachial plexus blocks. The aim of this study is to evaluate differences between ultrasound guided supraclavicular versus retroclavicular brachial plexus blocks, with primary focus on the incidence of diminished ipsilateral hemidiaphramatic excursion (ipsilateral phrenic nerve blockade). We will also evaluate differences between the two techniques in the success of producing surgical anesthesia, procedural time to perform the block (including imaging time and needling time), block onset time, ease of quality ultrasound needle visualization, and incidence of paresthesias, vascular puncture and pneumothorax. Lastly, we will observe and compare the distribution of motor and sensory blockade of the two techniques

Study Design

Study Type:
Interventional
Actual Enrollment :
44 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Ultrasound Guided Supraclavicular Brachial Plexus Block vs Retroclavicular Brachial Plexus Block: Comparison of Impact on Ipsilateral Diaphragmatic Function
Actual Study Start Date :
Dec 7, 2017
Actual Primary Completion Date :
Jun 20, 2019
Actual Study Completion Date :
Jun 21, 2019

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Supraclavicular BPNB

Patients in this group will be randomized to receive an Ultrasound Guided Supraclavicular Brachial Plexus Nerve Block and outcomes will be measured over the perioperative and 1day time period.

Procedure: Supraclavicular vs Retroclavicular Nerve Block
An ultrasound-guided supraclavicular or retroclavicular nerve block with 30 ml of 0.5% ropivicaine will be performed on patients scheduled for lower arm surgery; 25 ml to be delivered to the brachial plexus and 5 ml to the intercostal nerve

Active Comparator: Retroclavicular BNPB

Patients in this group will be randomized to receive an Ultrasound Guided Retroclavicular Brachial Plexus Nerve Block and outcomes will be measured over the perioperative and 1day time period.

Procedure: Supraclavicular vs Retroclavicular Nerve Block
An ultrasound-guided supraclavicular or retroclavicular nerve block with 30 ml of 0.5% ropivicaine will be performed on patients scheduled for lower arm surgery; 25 ml to be delivered to the brachial plexus and 5 ml to the intercostal nerve

Outcome Measures

Primary Outcome Measures

  1. Incidence of IIpsilateral Diaphragmatic Paresis [30 minutes post block, then postoperatively]

    As evidence by ipsilater diagphragmatic excursion measured by Mmode ultrasound

Secondary Outcome Measures

  1. Anesthetic and analgesic efficacy [30 minutes post block, then postoperatively]

    Block success will be defined as onset of acceptable sensory and motor blockade

  2. Procedural times (imaging time and needling time), onset time, ease of placement, and block duration [at the time of block]

    Ultrasonographic block imaging times (time between ultrasound probe placement on the patient and satisfactory image of target anatomy acquisition. needling time (time between needle insertion into the skin and the end of local anesthetic injection through the block needle), onset and duration of sensory block, and proceduralist's rating of ease of block performance will be measured.

  3. Complication rates [1 day]

    Rates of vascular puncture, pneumothorax and paresthesias will be recorded

  4. Nerve block distribution [30 minutes post block]

    measured through sensation (cold and pin prick) over dermatomes of the brachial plexus

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. patients scheduled for lower arm surgery

  2. patients aged 18 years or older

  3. patients ASA class I-III

Exclusion Criteria:
  1. Patients unable to cooperate or consent to the study

  2. pre-existing neuropathy

  3. significant pulmonary disease

  4. contralateral phrenic nerve or diaphragmatic dysfunction

  5. allergy to local anesthetics

  6. infection at needle insertion site

  7. history of coagulopathy

  8. BMI > 40 kg/m2

Contacts and Locations

Locations

Site City State Country Postal Code
1 Kamen Vlassakov Boston Massachusetts United States 02115

Sponsors and Collaborators

  • Brigham and Women's Hospital

Investigators

  • Principal Investigator: Kamen Vlassakov, MD, kvlassakov@partners.org

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Kamen Vlassakov, Director of Regional and Orthopedic Anesthesiology, Brigham and Women's Hospital
ClinicalTrials.gov Identifier:
NCT02631122
Other Study ID Numbers:
  • 2015P001537
First Posted:
Dec 16, 2015
Last Update Posted:
Oct 22, 2019
Last Verified:
Oct 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Kamen Vlassakov, Director of Regional and Orthopedic Anesthesiology, Brigham and Women's Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 22, 2019